Ivens A, Moore G, Williamson R
Department of Biochemistry and Molecular Genetics, St Mary's Hospital Medical School, London.
J Med Genet. 1988 Jul;25(7):473-9. doi: 10.1136/jmg.25.7.473.
The biochemical and physiological defects underlying human dysmorphic syndromes can now be approached using techniques of molecular biology. The genetic component of the causation of the dysmorphology can be studied in isolation from the environmental component by using large, rare families which exhibit the same phenotype as more complex multifactorial disorders, but inherit the mutation in a monogenic fashion. Such an analysis starts with the determination of linkage to a gene probe, followed by the use of newer techniques of molecular biology to enable cloning and sequencing of the mutated gene. Analysis of the gene product by amino acid sequence homology to other known proteins, and tissue specific expression, may place the defect within the cascade of events associated with development and differentiation. Once cloned, the gene can also be manipulated in transgenic laboratory animals and the effect of its mutation studied directly. The use of techniques of molecular biology to study the genetic aspects of dysmorphic syndromes will allow insight to be gained both into normal fetal development and into the causes of congenital malformations.
现在可以使用分子生物学技术来探究人类畸形综合征背后的生化和生理缺陷。通过研究大型稀有家族,可将畸形形成原因中的遗传成分与环境成分分开来研究。这些家族表现出与更复杂的多因素疾病相同的表型,但以单基因方式遗传突变。这种分析首先要确定与基因探针的连锁关系,然后使用更新的分子生物学技术对突变基因进行克隆和测序。通过与其他已知蛋白质的氨基酸序列同源性以及组织特异性表达来分析基因产物,可能会将缺陷置于与发育和分化相关的一系列事件中。一旦克隆出基因,也可以在转基因实验动物中对其进行操作,并直接研究其突变的影响。利用分子生物学技术研究畸形综合征的遗传方面,将有助于深入了解正常胎儿发育以及先天性畸形的成因。